Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Nup62cl | Rat | 1,2-dichloroethane | decreases expression | ISO | Nup62cl (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of NUP62CL mRNA | CTD | PMID:28960355 | Nup62cl | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of NUP62CL mRNA | CTD | PMID:22808131 | Nup62cl | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of NUP62CL mRNA | CTD | PMID:32109520 | Nup62cl | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | Nup62cl (Mus musculus) | 6480464 | bisphenol S results in increased expression of NUP62CL mRNA | CTD | PMID:30951980 | Nup62cl | Rat | 6-propyl-2-thiouracil | multiple interactions | ISO | Nup62cl (Mus musculus) | 6480464 | [Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of NUP62CL mRNA | CTD | PMID:36706583 | Nup62cl | Rat | aflatoxin B1 | affects expression | ISO | NUP62CL (Homo sapiens) | 6480464 | Aflatoxin B1 affects the expression of NUP62CL protein | CTD | PMID:20106945 | Nup62cl | Rat | aflatoxin B1 | increases methylation | ISO | NUP62CL (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of NUP62CL intron | CTD | PMID:30157460 | Nup62cl | Rat | aflatoxin B1 | increases expression | ISO | NUP62CL (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased expression of NUP62CL mRNA | CTD | PMID:21632981 | Nup62cl | Rat | all-trans-retinoic acid | decreases expression | ISO | NUP62CL (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of NUP62CL mRNA | CTD | PMID:23724009 | Nup62cl | Rat | all-trans-retinoic acid | increases expression | ISO | Nup62cl (Mus musculus) | 6480464 | Tretinoin results in increased expression of NUP62CL mRNA | CTD | PMID:36189433 | Nup62cl | Rat | all-trans-retinoic acid | multiple interactions | ISO | Nup62cl (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of NUP62CL mRNA | CTD | PMID:36189433 | Nup62cl | Rat | amphetamine | increases expression | EXP | | 6480464 | Amphetamine results in increased expression of NUP62CL mRNA | CTD | PMID:30779732 | Nup62cl | Rat | arsane | increases methylation | ISO | NUP62CL (Homo sapiens) | 6480464 | Arsenic results in increased methylation of NUP62CL promoter | CTD | PMID:21291286 | Nup62cl | Rat | arsane | multiple interactions | ISO | NUP62CL (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of NUP62CL mRNA | CTD | PMID:32525701 | Nup62cl | Rat | arsenic atom | increases methylation | ISO | NUP62CL (Homo sapiens) | 6480464 | Arsenic results in increased methylation of NUP62CL promoter | CTD | PMID:21291286 | Nup62cl | Rat | arsenic atom | multiple interactions | ISO | NUP62CL (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of NUP62CL mRNA | CTD | PMID:32525701 | Nup62cl | Rat | benzo[a]pyrene | increases expression | ISO | NUP62CL (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of NUP62CL mRNA | CTD | PMID:21632981 and PMID:32234424 | Nup62cl | Rat | benzo[a]pyrene | affects methylation | ISO | NUP62CL (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of NUP62CL 5' UTR | CTD | PMID:27901495 | Nup62cl | Rat | beta-lapachone | increases expression | ISO | NUP62CL (Homo sapiens) | 6480464 | beta-lapachone results in increased expression of NUP62CL mRNA | CTD | PMID:38218311 | Nup62cl | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of NUP62CL mRNA | CTD | PMID:25181051 | Nup62cl | Rat | bisphenol F | increases expression | ISO | Nup62cl (Mus musculus) | 6480464 | bisphenol F results in increased expression of NUP62CL mRNA | CTD | PMID:38685157 | Nup62cl | Rat | cadmium atom | decreases expression | ISO | NUP62CL (Homo sapiens) | 6480464 | Cadmium results in decreased expression of NUP62CL mRNA | CTD | PMID:24376830 | Nup62cl | Rat | cadmium atom | multiple interactions | ISO | NUP62CL (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NUP62CL mRNA | CTD | PMID:35301059 | Nup62cl | Rat | cadmium dichloride | multiple interactions | ISO | NUP62CL (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NUP62CL mRNA | CTD | PMID:35301059 | Nup62cl | Rat | calcitriol | increases expression | ISO | NUP62CL (Homo sapiens) | 6480464 | Calcitriol results in increased expression of NUP62CL mRNA | CTD | PMID:16002434 | Nup62cl | Rat | calcitriol | multiple interactions | ISO | NUP62CL (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of NUP62CL mRNA | CTD | PMID:21592394 | Nup62cl | Rat | calcitriol | decreases expression | ISO | NUP62CL (Homo sapiens) | 6480464 | Calcitriol results in decreased expression of NUP62CL mRNA | CTD | PMID:21592394 | Nup62cl | Rat | carbamazepine | affects expression | ISO | NUP62CL (Homo sapiens) | 6480464 | Carbamazepine affects the expression of NUP62CL mRNA | CTD | PMID:25979313 | Nup62cl | Rat | cisplatin | multiple interactions | ISO | NUP62CL (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of NUP62CL mRNA | CTD | PMID:27392435 | Nup62cl | Rat | cisplatin | increases expression | ISO | NUP62CL (Homo sapiens) | 6480464 | Cisplatin results in increased expression of NUP62CL mRNA | CTD | PMID:27392435 | Nup62cl | Rat | cobalt dichloride | decreases expression | ISO | NUP62CL (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of NUP62CL mRNA | CTD | PMID:19376846 | Nup62cl | Rat | copper(II) sulfate | decreases expression | ISO | NUP62CL (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of NUP62CL mRNA | CTD | PMID:19549813 | Nup62cl | Rat | coumestrol | increases expression | ISO | NUP62CL (Homo sapiens) | 6480464 | Coumestrol results in increased expression of NUP62CL mRNA | CTD | PMID:19167446 | Nup62cl | Rat | coumestrol | multiple interactions | ISO | NUP62CL (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUP62CL mRNA | CTD | PMID:19167446 | Nup62cl | Rat | cyclosporin A | increases expression | ISO | NUP62CL (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of NUP62CL mRNA | CTD | PMID:20106945 and PMID:27989131 | Nup62cl | Rat | cyclosporin A | decreases expression | ISO | NUP62CL (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of NUP62CL mRNA | CTD | PMID:25562108 | Nup62cl | Rat | diiodine | multiple interactions | ISO | Nup62cl (Mus musculus) | 6480464 | [Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of NUP62CL mRNA | CTD | PMID:36706583 | Nup62cl | Rat | dorsomorphin | multiple interactions | ISO | NUP62CL (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Nup62cl | Rat | Enterolactone | multiple interactions | ISO | NUP62CL (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUP62CL mRNA | CTD | PMID:19167446 | Nup62cl | Rat | ethanol | increases expression | ISO | NUP62CL (Homo sapiens) | 6480464 | Ethanol results in increased expression of NUP62CL mRNA | CTD | PMID:28986285 | Nup62cl | Rat | methotrexate | increases expression | ISO | NUP62CL (Homo sapiens) | 6480464 | Methotrexate results in increased expression of NUP62CL mRNA | CTD | PMID:24449571 | Nup62cl | Rat | mono(2-ethylhexyl) phthalate | multiple interactions | ISO | Nup62cl (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of NUP62CL mRNA | CTD | PMID:36189433 | Nup62cl | Rat | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of NUP62CL mRNA | CTD | PMID:25729387 | Nup62cl | Rat | p-chloromercuribenzoic acid | decreases expression | ISO | NUP62CL (Homo sapiens) | 6480464 | p-Chloromercuribenzoic Acid results in decreased expression of NUP62CL mRNA | CTD | PMID:26272509 | Nup62cl | Rat | p-chloromercuribenzoic acid | multiple interactions | ISO | NUP62CL (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NUP62CL mRNA | CTD | PMID:27188386 | Nup62cl | Rat | paracetamol | increases expression | ISO | NUP62CL (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of NUP62CL mRNA | CTD | PMID:22230336 | Nup62cl | Rat | paracetamol | decreases expression | ISO | NUP62CL (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of NUP62CL mRNA | CTD | PMID:26690555 | Nup62cl | Rat | perfluorohexanesulfonic acid | increases expression | ISO | Nup62cl (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in increased expression of NUP62CL mRNA | CTD | PMID:37995155 | Nup62cl | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Nup62cl (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of NUP62CL mRNA | CTD | PMID:36331819 | Nup62cl | Rat | quercetin | increases expression | ISO | NUP62CL (Homo sapiens) | 6480464 | Quercetin results in increased expression of NUP62CL mRNA | CTD | PMID:21632981 | Nup62cl | Rat | SB 431542 | multiple interactions | ISO | NUP62CL (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Nup62cl | Rat | silicon dioxide | decreases expression | ISO | NUP62CL (Homo sapiens) | 6480464 | Silicon Dioxide results in decreased expression of NUP62CL mRNA | CTD | PMID:25351596 | Nup62cl | Rat | sodium arsenate | multiple interactions | ISO | NUP62CL (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of NUP62CL mRNA | CTD | PMID:32525701 | Nup62cl | Rat | sodium arsenite | decreases expression | ISO | NUP62CL (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of NUP62CL mRNA | CTD | PMID:38568856 | Nup62cl | Rat | sunitinib | decreases expression | ISO | NUP62CL (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of NUP62CL mRNA | CTD | PMID:31533062 | Nup62cl | Rat | testosterone | multiple interactions | ISO | NUP62CL (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of NUP62CL mRNA | CTD | PMID:21592394 | Nup62cl | Rat | testosterone | decreases expression | ISO | NUP62CL (Homo sapiens) | 6480464 | Testosterone results in decreased expression of NUP62CL mRNA | CTD | PMID:21592394 | Nup62cl | Rat | thalidomide | decreases expression | ISO | Nup62cl (Mus musculus) | 6480464 | Thalidomide results in decreased expression of NUP62CL mRNA | CTD | PMID:26217789 | Nup62cl | Rat | thiram | decreases expression | ISO | NUP62CL (Homo sapiens) | 6480464 | Thiram results in decreased expression of NUP62CL mRNA | CTD | PMID:38568856 | Nup62cl | Rat | titanium dioxide | decreases methylation | ISO | Nup62cl (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of NUP62CL gene | CTD | PMID:35295148 | Nup62cl | Rat | titanium dioxide | decreases expression | ISO | Nup62cl (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of NUP62CL mRNA | CTD | PMID:35295148 | Nup62cl | Rat | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of NUP62CL mRNA | CTD | PMID:25729387 | Nup62cl | Rat | torcetrapib | increases expression | ISO | NUP62CL (Homo sapiens) | 6480464 | torcetrapib results in increased expression of NUP62CL mRNA | CTD | PMID:23228038 | Nup62cl | Rat | triclosan | decreases expression | ISO | NUP62CL (Homo sapiens) | 6480464 | Triclosan results in decreased expression of NUP62CL mRNA | CTD | PMID:30510588 | Nup62cl | Rat | valproic acid | affects expression | ISO | NUP62CL (Homo sapiens) | 6480464 | Valproic Acid affects the expression of NUP62CL mRNA | CTD | PMID:25979313 | Nup62cl | Rat | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of NUP62CL mRNA | CTD | PMID:35594946 | Nup62cl | Rat | valproic acid | increases expression | ISO | NUP62CL (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of NUP62CL mRNA | CTD | PMID:24383497 more ... | Nup62cl | Rat | valproic acid | multiple interactions | ISO | NUP62CL (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NUP62CL mRNA | CTD | PMID:27188386 | Nup62cl | Rat | vorinostat | increases expression | ISO | NUP62CL (Homo sapiens) | 6480464 | vorinostat results in increased expression of NUP62CL mRNA | CTD | PMID:27188386 | |